Valiant Laboratories balance sheet

As of Mar 2026

Total assets: ₹464cr+15.7% on Mar 2025
Shareholders' equity: ₹311cr+32.7% on Mar 2025
Total debt: ₹44.9cr−62.9% on Mar 2025
Cash and investments: ₹29.6cr+502.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024

Non-current assets
	227	48.3	50.1
	6.1	156	42.6
	0.1	0.1	0.0
	2.4	3.6	3.4
	2.4	3.6	3.4
	0.0	0.5	21.0
	236	208	117
Current assets
	45.4	4.0	10.0
	26.1	0.0	37.6
	93.6	72.1	45.7
	3.5	4.9	11.7
	3.5	71.1	94.5
	0.0	0.1	0.0
	127	148	190
	54.5	38.3	21.9
	228	193	226
	464	401	343
Equity
	54.3	43.5	43.5
	257	191	193
	311	234	237
	311	234	237
Liabilities
	28.1	104	74.7
	1.8	1.2	1.4
	29.9	106	76.1
	0.1	0.1	0.1
	3.6	1.2	0.6
	33.6	107	76.7
	16.9	16.9	1.4
	94.0	40.7	25.9
	2.7	1.6	1.4
	114	59.2	28.8
	0.3	0.2	0.1
	5.5	0.3	0.2
	119	59.6	29.1
	153	167	106
	464	401	343
Assets — additional as-filed lines
	1.7	2.2	4.1
Trade payables — MSME split
	2.9	3.8	—
	91.1	36.9	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

VALIANTLAB₹125.82

Valiant Laboratories Limited

· Pharma & Health

₹ CrorePeersALBERTDAVD HALEOSLABS ZIMLAB MEDICO MEDICAMEQ ANUHPHR AHCL WANBURYMcap ₹683 Cr

View

In ₹ Crore except Per Share As of	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	50.1	48.3	227.0	227.0
+ Capital Work-in-Progress	42.6	155.8	6.1	6.1
+ Other Intangibles	0.0	0.1	0.1	0.1
+ Other Non-current Financial Assets	3.4	3.6	2.4	2.4
Non-current Financial Assets	3.4	3.6	2.4	2.4
+ Other Non-current Assets	21.0	0.5	0.0	0.0
Total Non-current Assets	117.1	208.2	235.7	235.7
Current Assets
+ Inventories	10.0	4.0	45.4	45.4
+ Current Investments	37.6	0.0	26.1	26.1
+ Trade Receivables	45.7	72.1	93.6	93.6
+ Cash & Cash Equivalents	11.7	4.9	3.5	3.5
+ Other Bank Balances	94.5	71.1	3.5	3.5
+ Short-term Loans	0.0	0.1	0.0	0.0
Current Financial Assets	189.6	148.2	126.8	126.8
+ Other Current Assets	21.9	38.3	54.5	54.5
Total Current Assets	225.5	192.6	228.3	228.3
Total Assets	342.7	400.9	464.0	464.0
Equity
+ Equity Share Capital	43.5	43.5	54.3	54.3
+ Other Equity / Reserves	193.4	190.9	256.6	256.6
Equity — Owners of Parent	236.9	234.3	310.9	310.9
Total Equity	236.9	234.3	310.9	310.9
Liabilities
+ Borrowings — Non-current	74.7	104.3	28.1	28.1
+ Other Non-current Financial Liab	1.4	1.2	1.8	1.8
Non-current Financial Liabilities	76.1	105.6	29.9	29.9
+ Provisions — Non-current	0.1	0.1	0.1	0.1
+ Deferred Tax Liabilities	0.6	1.2	3.6	3.6
Non-current Liabilities	76.7	106.9	33.6	33.6
+ Borrowings — Current	1.4	16.9	16.9	16.9
+ Trade Payables	25.9	40.7	94.0	94.0
+ Other Current Financial Liab	1.4	1.6	2.7	2.7
Current Financial Liabilities	28.8	59.2	113.6	113.6
+ Provisions — Current	0.1	0.2	0.3	0.3
+ Other Current Liabilities	0.2	0.3	5.5	5.5
Current Liabilities	29.1	59.6	119.4	119.4
Total Liabilities	105.8	166.5	153.1	153.1
Total Equity & Liabilities	342.7	400.9	464.0	464.0
Assets — additional as-filed lines
+ Current Tax Assets	4.1	2.2	1.7	1.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	3.8	2.9	2.9
+ Dues to Other Creditors — Current	—	36.9	91.1	91.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.